Will Nasdaq’s (NDAQ) New Data Partnership Redefine Its Edge in Institutional Analytics?

• Premialab recently announced a partnership with Nasdaq eVestment™, integrating their data analytics platforms to provide institutional investors with enhanced tools for strategy analysis, portfolio construction, and risk monitoring.
• This collaboration gives users seamless access to expansive datasets and proprietary quantitative indices, streamlining research workflows and supporting comprehensive investment insights within a unified environment.
• We'll explore how the expanded analytical ecosystem could influence Nasdaq's long-term product innovation and competitive positioning.

This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.

Nasdaq Investment Narrative Recap

To stay invested in Nasdaq today, you need conviction in its evolving technology platform and its ability to maintain product leadership as data and analytics demands grow. The new Premialab partnership gives clients deeper access to analytics and data but is unlikely to significantly shift immediate revenue catalysts or fully address the most important risk: ongoing competition among exchanges and fintechs shaping future growth.

Among recent announcements, Nasdaq’s extension of its licensing agreement with CME Group for Nasdaq-100 futures and options trading stands out. This move solidifies liquidity and reach in listed derivatives, which could play a supporting role for Nasdaq’s long-term efforts to differentiate through innovation and partnerships like the new Premialab deal.

In contrast, rising competition from both exchanges and fintechs remains a risk investors should be aware of, especially as new technology alliances multiply...

Read the full narrative on Nasdaq (it's free!)

Nasdaq’s outlook anticipates $6.1 billion in revenue and $2.0 billion in earnings by 2028. This reflects a 9.2% annual decline in revenue and a $0.5 billion increase in earnings from the current $1.5 billion.

Uncover how Nasdaq's forecasts yield a $100.67 fair value, a 7% upside to its current price.

Exploring Other Perspectives

Seven Simply Wall St Community members have valued Nasdaq anywhere from US$37.13 to US$100.67 per share. Against this wide spread of fair value opinions, the technology partnership with Premialab points to the importance of data-driven innovation in shaping future earnings and market share. Explore several viewpoints in the community for a bigger picture.

Explore 7 other fair value estimates on Nasdaq - why the stock might be worth less than half the current price!

Build Your Own Nasdaq Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Nasdaq research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Nasdaq research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Nasdaq's overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find companies with promising cash flow potential yet trading below their fair value.
• The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com